Healthcare · Pharmaceuticals & Biotechnology
| Name | Category | Shares % | Shares |
|---|---|---|---|
| NOVARTIS AG | Promoter | 70.6800% | 17450680 |
| Atul Limited | Public | 1.5200% | 374627 |
As of June 30, 2026. Only holders the filing discloses individually.
Promoters holdings were unchanged at 70.68% in Jun 2026 qtr
FII/FPI holdings decreased from 0.17% to 0.16% in Jun 2026 qtr
Mutual funds holdings increased from 0.00% to 0.69% in Jun 2026 qtr
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Latest change |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 70.68% | 70.68% | 70.68% | 70.68% | 70.68% | 70.68% | 70.68% | 70.68% | 0.00 pp |
| FII | 0.16% | 0.17% | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | 0.19% | -0.01 pp |
| DII | 1.36% | 0.53% | 0.64% | 0.53% | 0.53% | 0.53% | 0.53% | 0.53% | 0.83 pp |
| Mutual funds (within DII) | 0.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.69 pp |
| Public (non-institutional) | 27.80% | 28.62% | 28.49% | 28.60% | 28.60% | 28.60% | 28.60% | 28.60% | -0.82 pp |
Public (non-institutional) = SEBI's Public total minus FII minus DII, shown only where all three were filed. A dash means that holder category filed nothing for that quarter. Holder counts are as filed (entities, not schemes).
| Category | % holding | Shareholders |
|---|---|---|
| Grand Total | 100.0000 | 36502 |
| (A) Promoter & Promoter Group | 70.6800 | 1 |
| (B) Public | 29.3200 | 36501 |
| (C1) Shares underlying DRs | 0.0000 | 0 |
| (C) Non Promoter-Non Public | 0.0000 | 0 |
| (C2) Shares held by Employee Trust | 0.0000 | 0 |
Individually-disclosed large holders as of June 30, 2026 -- the filing only names holders large/notable enough to be individually disclosed, not every real shareholder.
| Name | Category | % holding | Shares |
|---|---|---|---|
| NOVARTIS AG | Promoter · Bodies Corporate | 70.6800 | 17450680 |
| Atul Limited | Public · Details Of Shares Held By Bodies Corporate | 1.5200 | 374627 |
